Evidence map›Paper›PMID 42906941›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2026

Haemoptysis in chronic pulmonary vascular disease: a narrative review.

Jan C Kamp, Brandon Budhram, Mitja Jevnikar, Karen M Olsson, Matti J Peperhove, Lavinia Neubert, Marius M Hoeper, Marc Humbert

Abstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jan C KampDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0000-0002-5002-409X
Brandon BudhramDivision of Respirology, Department of Medicine, University of Calgary, Calgary, AB, Canada.ORCID https://orcid.org/0009-0006-3991-6544
Mitja JevnikarUniversité Paris-Saclay, Inserm UMR_S 1358 (HPPIT), Department of Respiratory and Intensive Care Medicine, Hôpital Bicêtre (AP-HP), FHU André Cournand, ERN-LUNG, Le Kremlin-Bicêtre, France.
Karen M OlssonDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Matti J PeperhoveInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Lavinia NeubertBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Marius M HoeperDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany Hoeper.Marius@mh-hannover.de.ORCID https://orcid.org/0000-0001-9086-2293
Marc HumbertUniversité Paris-Saclay, Inserm UMR_S 1358 (HPPIT), Department of Respiratory and Intensive Care Medicine, Hôpital Bicêtre (AP-HP), FHU André Cournand, ERN-LUNG, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0003-0703-2892

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Haemoptysis, the expectoration of blood from the lower airways, is a complication of several pulmonary vascular diseases (PVDs). The pathophysiology of haemoptysis in chronic PVDs is complex and varies depending on the underlying condition. Computed tomography pulmonary angiography remains the gold standard for localising the bleeding source and guiding interventional therapies. Management of haemoptysis in patients with chronic PVDs can range from oxygen supplementation to angiography-guided bronchial artery embolisation, depending on bleeding severity, anatomical features and specific features of the associated disease. Regardless of the management strategy, long-term follow-up is essential in these patients owing to the risk of recurrent bleeding. The aim of this review is to comprehensively explore the characteristics of haemoptysis in selected chronic PVDs, summarise current knowledge of the pathophysiology, and provide guidance on contemporary diagnostic and treatment strategies.

Indexed as

HemoptysisPulmonary ArteryBronchial ArteriesChronic DiseaseComputed Tomography AngiographyEmbolization, TherapeuticHumansPredictive Value of TestsRisk FactorsTreatment Outcome

Identifiers

PMID42906941
PMCPMC13684417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.